We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.12B
AUM Growth
-$199M
Cap. Flow
-$200M
Cap. Flow %
-3.9%
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94

Top Sells

Rank Stock Value
1
BEAV
B/E Aerospace Inc
BEAV
+$48.6M
2
VTR icon
Ventas
VTR
+$42.2M
3
CNC icon
Centene
CNC
+$38.9M
4
MANH icon
Manhattan Associates
MANH
+$30.4M
5
CRM icon
Salesforce
CRM
+$24.4M

Sector Composition

Rank Sector Weight
1 Healthcare 16.09%
2 Financials 14.79%
3 Technology 14.28%
4 Consumer Discretionary 14.11%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$640B
$14.8M 0.29%
128,164
+40,189
+46% +$4.64M
BERY
77
DELISTED
Berry Global Group, Inc.
BERY
$14.4M 0.28%
322,034
+312,995
+3,463% +$13.4M
GWRE icon
78
Guidewire Software
GWRE
$16.7B
$14.3M 0.28%
290,328
-31,886
-10% -$1.79M
WOOF
79
DELISTED
VCA Inc.
WOOF
$13.9M 0.27%
202,997
-6,512
-3% -$425K
BRK.B icon
80
Berkshire Hathaway Class B
BRK.B
$1.08T
$13.8M 0.27%
84,567
-2,203
-3% -$339K
HII icon
81
Huntington Ingalls Industries
HII
$11.7B
$13.7M 0.27%
74,602
+67,027
+885% +$11.4M
IJR icon
82
iShares Core S&P Small-Cap ETF
IJR
$111B
$13.3M 0.26%
193,854
+8,034
+4% +$518K
SYNH
83
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$13.1M 0.25%
248,263
+242,178
+3,980% +$11.7M
SPY icon
84
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$12M 0.23%
53,519
+27,229
+104% +$5.95M
PEP icon
85
PepsiCo
PEP
$191B
$11.9M 0.23%
113,479
-3,036
-3% -$318K
AON icon
86
Aon
AON
$74.2B
$11.7M 0.23%
105,292
+309
+0.3% +$34.4K
IWM icon
87
iShares Russell 2000 ETF
IWM
$81.9B
$11.2M 0.22%
83,144
+1,882
+2% +$240K
XOM icon
88
ExxonMobil
XOM
$643B
$11.2M 0.22%
123,869
-7,244
-6% -$633K
CTSH icon
89
Cognizant
CTSH
$28.7B
$10.8M 0.21%
193,444
-19,871
-9% -$1.06M
GE icon
90
GE Aerospace
GE
$356B
$10.2M 0.2%
67,512
-1,723
-2% -$250K
BA icon
91
Boeing
BA
$166B
$10.2M 0.2%
65,405
-3,007
-4% -$439K
CME icon
92
CME Group
CME
$101B
$9.93M 0.19%
86,047
+200
+0.2% +$22.3K
SLB icon
93
SLB Ltd
SLB
$81.6B
$9.17M 0.18%
109,208
+35,988
+49% +$2.95M
GILD icon
94
Gilead Sciences
GILD
$185B
$8.61M 0.17%
120,257
-780
-0.6% -$58K
PG icon
95
Procter & Gamble
PG
$333B
$8.27M 0.16%
98,376
+2,222
+2% +$189K
BKNG icon
96
Booking.com
BKNG
$152B
$7.85M 0.15%
133,925
-1,925
-1% -$115K
MCO icon
97
Moody's
MCO
$88.2B
$7.82M 0.15%
82,936
-3,952
-5% -$399K
PGX icon
98
Invesco Preferred ETF
PGX
$3.74B
$7.21M 0.14%
507,008
-204,526
-29% -$2.98M
PFE icon
99
Pfizer
PFE
$160B
$6.98M 0.14%
226,496
-3,605
-2% -$110K
DIS icon
100
Walt Disney
DIS
$184B
$6.74M 0.13%
64,656
-797
-1% -$77.7K

Similar funds

Geneva Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.

  • Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
  • Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
  • Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
  • Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
  • Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
  • Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.

Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.